Skip to main content

Table 2 Associations between miRNAs and clinicopathological features studied in current meta-analysis

From: Systematic review and meta-analysis of the prognostic significance of microRNAs related to metastatic and EMT process among prostate cancer patients

Clinicopathological features miRNAs Figures
Presence of metastasis
 GM miR-410-3p, miR-132, miR-212, miR-802, miR-141-3p, miR-210-3p, miR-301a, miR-503, miR-543 Figure 2a
 LNM miR-802, miR-301a, miR-503 Figure 2b
 DM miR-132, miR-212, miR-802, miR-141-3p, miR-210-3p Figure 2c
 BM miR-141-3p, miR-210-3p Figure 2d
Total Gleasone scor
 GS > 6 miR-410-3p, miR-132, miR-212, miR-203, miR-409-3p, miR-409-5p, miR-301a, miR-466, miR-503, miR-543, miR-573, miR-3622a Figure 2e
 GS > 7 miR-132, miR-212, miR-802, miR-141-3p, miR-210-3p, miR-203, miR-409-3p, miR-409-5p, miR-301a, miR-466, miR-503, miR-543, miR-573, miR-3622a Figure 2f
 pT stage according to TNM miR-410-3p, miR-132, miR-212, miR-802, miR-203, miR-301a, miR-466, miR-503, miR-543, miR-573, miR-3622a Figure 2g
  1. GM general metastasis, LNM lymph node metastasis, DM distant metastasis, BM bone metastasis, GS Gleason score, pT stage-pathological tumor stage